Biocon surges on getting nod to transfer biosimilars business

11 Dec 2017 Evaluate

Biocon is currently trading at Rs. 527.05, up by 5.45 points or 1.04% from its previous closing of Rs. 521.60 on the BSE.

The scrip opened at Rs. 521.00 and has touched a high and low of Rs. 530.00 and Rs. 520.25 respectively. So far 145713 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 530.00 on 11-Dec-2017 and a 52 week low of Rs. 294.03 on 27-Dec-2016.

Last one week high and low of the scrip stood at Rs. 530.00 and Rs. 483.00 respectively. The current market cap of the company is Rs. 31686.00 crore.

The promoters holding in the company stood at 60.67%, while institutions and non-institutions held 19.23% and 20.10% respectively.

Biocon has received its shareholders’ approval to the resolution for transfer of biosimilars business by way of a slump sale to group entity Biocon Biologics India. The resolution for transfer of Biosimilars business of the company by way of a slump sale as ‘Going Concern’ to Biocon Biologics India has been passed by the members of the company with requisite majority. The special resolution was passed with 99.99 per cent of votes polled through postal ballot.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

289.55 9.20 (3.28%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.